Viewing Study NCT06532032


Ignite Creation Date: 2025-12-24 @ 9:35 PM
Ignite Modification Date: 2026-05-27 @ 4:44 AM
Study NCT ID: NCT06532032
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer
Sponsor: Janssen Research & Development, LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords: